ArticleJCO precision oncology2025
Somatic Mutation Profiles of Colorectal Cancer by Birth Cohort.
Article in JCO precision oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
purposeIncidence rates of early-onset colorectal cancer (CRC) have risen globally, with younger birth cohorts-individuals born after 1960-experiencing higher rates. However, whether somatic mutation profiles vary across birth cohorts remains unclear. This study examines differences in the mutational landscape of CRC by birth cohort.
methodsColorectal tumors that underwent somatic next-generation sequencing (NGS) for 154-168 genes in an in-house laboratory between 2015 and 2022 were retrospectively identified. Microsatellite instability status was determined by NGS as either microsatellite stable (MSS) or microsatellite instability-high (MSI-H). Patients with hereditary cancer syndromes or inflammatory bowel disease were excluded. Genes were then grouped according to their molecular pathway. Associations between somatic mutations and birth cohorts were assessed using univariable and multivariable logistic regression. Associations were adjusted for CRC stage, location, neoadjuvant chemo/radiotherapy, and age.
resultsOverall, 369 patients with CRC were identified. The median birth year was 1955 (IQR, 1947-1963) and the median age at diagnosis of CRC was 62.9 (IQR, 52.9-70.8). Twenty (5.4%) had MSI-H tumors and were analyzed separately from MSS tumors. Patients with MSI-H tumors had an earlier birth year than patients with MSS (median 1946
conclusionIn this study, mutational landscape of CRC did not differ by birth cohort, suggesting that the observed shifts in CRC incidence across generations are unlikely to be driven by changes in tumor genomics. However, larger studies are needed to validate these findings.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.